Finance

Lists
19X:FRA
Axsome Therapeutics Inc
€137.50
0.00%
(0.00) 1D
Oct 19, 8:15:01 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 19X...
Mkt. cap
8.16B
Avg. vol.
13.00
Volume
0.00
52-wk high
€221.20
52-wk low
€108.40
No. of employees
1K
Mkt. cap
8.16B
Avg. vol.
13.00
Volume
0.00
52-wk high
€221.20
52-wk low
€108.40
No. of employees
1K
News stories
From web sources and news partners
About Axsome Therapeutics Inc
CEOHerriot Tabuteau
Employees1.35K
Founded2012
Headquarters-
SectorPharmaceutical industry
Websiteaxsome.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
170.99M
196.00M
191.20M
218.38M
Cost of goods sold
11.91M
12.33M
14.72M
13.56M
Cost of revenue
11.91M
12.33M
14.72M
13.56M
Research and development expenses
40.16M
48.79M
52.68M
46.23M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
150.24M
169.30M
185.00M
208.14M
Operating expense
192.00M
219.70M
239.24M
255.95M
Total operating expenses
203.92M
232.02M
253.97M
269.52M
Operating income
-32.92M
-36.02M
-62.77M
-51.14M
Other non operating income
-
-
-
-
EBT including unusual items
-47.23M
-28.13M
-64.54M
-51.19M
EBT excluding unusual items
-34.04M
-37.20M
-63.95M
-52.68M
Income tax expense
-
430.00K
-
128.00K
Effective tax rate
-
-1.53%
-
-0.25%
Other operating expenses
-
-
-
-
Net income
-47.23M
-28.56M
-64.54M
-51.31M
Net profit margin
-27.62%
-14.57%
-33.76%
-23.50%
Earnings per share
-0.94
-0.56
-1.26
-0.99
Interest and investment income
2.26M
2.04M
1.91M
1.66M
Interest expense
-3.38M
-3.21M
-3.09M
-3.20M
Net interest expenses
-1.12M
-1.17M
-1.18M
-1.54M
Depreciation and amortization charges
-
-
-
-
EBITDA
-30.51M
-33.75M
-60.40M
-48.26M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps